
The Biomedical Inflection Point: Navigating the Macro Risks of GLP-1 Expansion and Stagnant Research Funding
The convergence of rapid GLP-1 adoption, a robust Alzheimer's pipeline, and stagnant NIH funding has created a fragile macroeconomic equilibrium in bi...
Read Full Story →




